Evolent Health, Inc Class A (EVH)
EVH moved a median of -0.04% 30 minutes after news, and -0.09% by the close. How EVH actually reacts to news — the realized, point-in-time move the market made, measured across 256 labeled events over the last three years with zero look-ahead.
EVH’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 50% | 255 |
| 30-min | -0.04% | 49% | 256 |
| 60-min | -0.23% | 45% | 256 |
| to close | -0.09% | 48% | 250 |
| Middle 50% of EVH reactions | -1.71% to +1.22% |
|---|---|
| Median reaction (30-min) | -0.04% |
| Measured reactions | 256 |
Half of all Evolent Health, Inc Class A news events land between -1.71% and +1.22% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How EVH reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 15 | -0.94% | 33% | -0.73% |
| Analyst downgrades | 14 | -1.19% | 43% | -0.64% |
| Coverage initiations | 22 | -0.61% | 36% | -0.25% |
| Rating reiterations | 103 | +0.16% | 54% | -0.23% |
| Price-target cuts | 42 | -0.32% | 36% | 0.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how EVH ranks against every other measured name →
That’s how EVH usually reacts — get an email when it moves on news →Email me when EVH moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to EVH's baseline. Nothing else.
Recent EVH events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026 | Press release | PR Newswire | +0.62% | +5.20% | |
| TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation | Press release | GlobeNewswire | -0.28% | +1.51% | |
| Evolent Announces Second Quarter 2026 Results | Press release | PR Newswire | -1.94% | -7.00% | |
| Form 10-Q Evolent Health, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.94% | -7.00% | |
| Form 8-K Evolent Health, Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | -1.94% | -7.00% | |
| Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 | Press release | PR Newswire | +1.00% | +2.92% | |
| Form S-8 Evolent Health, Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.90% | +2.92% | |
| Form 8-K Evolent Health, Inc. For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.20% | -3.65% | |
| Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer | Press release | PR Newswire | -3.29% | +5.32% | |
| Evolent Announces First Quarter 2026 Results | Press release | PR Newswire | +5.86% | +16.99% | |
| Form 10-Q Evolent Health, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +5.86% | +16.99% | |
| Form 8-K Evolent Health, Inc. For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +5.86% | +16.99% | |
| Form ARS Evolent Health, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +4.87% | +12.66% | |
| Form DEF 14A Evolent Health, Inc. For: Jun 04 | SEC filing · Form DEF | SEC EDGAR | +4.87% | +12.66% | |
| Form DEFA14A Evolent Health, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +4.87% | +12.66% | |
| Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 | Press release | PR Newswire | +0.00% | -5.54% | |
| Evolent announces appointment of Archie Mayani as chief product officer | Press release | PR Newswire | +0.74% | +3.40% | |
| Foodsmart Appoints Cityblock Health Co-Founder and CEO Dr. Toyin Ajayi to Board of Directors | Press release | PR Newswire | +0.00% | -3.96% | |
| Evolent to Participate in Upcoming Investor Conferences | Press release | PR Newswire | -0.61% | -0.92% | |
| Form 10-K Evolent Health, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +10.76% | +25.10% | |
| Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results | Press release | PR Newswire | +10.76% | +25.10% | |
| Form 8-K Evolent Health, Inc. For: Feb 24 | SEC filing · Form 8-K | SEC EDGAR | +10.76% | +25.10% | |
| Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 | Press release | PR Newswire | -0.29% | -2.83% | |
| Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 | Press release | PR Newswire | +1.03% | +2.07% | |
| Form S-8 Evolent Health, Inc. | SEC filing · Form S-8 | SEC EDGAR | +1.03% | +2.07% | |
| Form 8-K Evolent Health, Inc. For: Dec 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.44% | |
| Form 8-K Evolent Health, Inc. For: Dec 01 | SEC filing · Form 8-K | SEC EDGAR | +0.75% | -2.76% | |
| Form 10-Q Evolent Health, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.41% | -19.09% | |
| Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden | Press release | PR Newswire | +0.41% | -19.09% | |
| Evolent Announces Third Quarter 2025 Results | Press release | PR Newswire | +0.41% | -19.09% | |
| Form 8-K Evolent Health, Inc. For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | +0.41% | -19.09% | |
| Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 | Press release | PR Newswire | +0.31% | +1.62% | |
| Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners | Press release | PR Newswire | +5.36% | +13.19% | |
| Form 8-K Evolent Health, Inc. For: Sep 23 | SEC filing · Form 8-K | SEC EDGAR | +5.36% | +13.19% | |
| Form 8-K Evolent Health, Inc. For: Aug 18 | SEC filing · Form 8-K | SEC EDGAR | -1.45% | +7.38% | |
| Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock | Press release | PR Newswire | +1.05% | — | |
| Form 8-K Evolent Health, Inc. For: Aug 18 | SEC filing · Form 8-K | SEC EDGAR | +1.05% | — | |
| Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock | Press release | PR Newswire | +1.05% | — | |
| Form 8-K Evolent Health, Inc. For: Aug 18 | SEC filing · Form 8-K | SEC EDGAR | +1.05% | — | |
| Form 10-Q Evolent Health, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.87% | +0.44% | |
| Evolent Announces Second Quarter 2025 Results | Press release | PR Newswire | +3.01% | +8.43% | |
| Form 8-K Evolent Health, Inc. For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +3.01% | +8.43% | |
| Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 | Press release | PR Newswire | +0.41% | +2.34% | |
| Evolent announces key appointments to leadership team | Press release | PR Newswire | -0.34% | -5.37% | |
| Evolent reiterates Q2 and full year guidance for Adjusted EBITDA | Press release | PR Newswire | +0.79% | +4.05% | |
| Form 8-K Evolent Health, Inc. For: Jun 19 | SEC filing · Form 8-K | SEC EDGAR | +0.79% | +4.05% | |
| Form S-8 Evolent Health, Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.67% | -4.00% | |
| Form 8-K Evolent Health, Inc. For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | +0.83% | -1.19% | |
| Form 8-K Evolent Health, Inc. For: Jun 03 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +12.65% | |
| Form 10-Q Evolent Health, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -4.71% | -21.10% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the EVH section they belong to.
Where else EVH is measured.
EVH earnings → · Analyst actions → · SEC filings →
Other Technology names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| iQIYI, Inc. - American Depositary Shares (IQ) | 262 | +0.07% | 50% |
| Amdocs Limited - Ordinary Shares (DOX) | 260 | +0.02% | 51% |
| Omnicell, Inc. (OMCL) | 256 | +0.09% | 54% |
| AudioEye, Inc. (AEYE) | 255 | -0.26% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Technology names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Evolent Health, Inc Class A's median reaction calculated?
Every labeled EVH news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 256 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of EVH's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does EVH's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.